9,092 results match your criteria: "Bulimia Nervosa"
J Child Adolesc Psychopharmacol
December 2024
New Jersey Poison Information and Education System, Department of Emergency Medicine, New Jersey Medical School Rutgers Biomedical and Health Sciences, Newark, New Jersey, USA.
While available for decades, the use of bupropion has increased in recent years. To provide an updated review on the use of bupropion, this article aimed to describe bupropion prescription details, potential indication, and treatment duration in children, young adults, and adults starting bupropion treatment. Individuals aged 6-64 newly initiating bupropion hydrochloride treatment were identified from commercial claims data (MarketScan, 1/1/2016-12/31/2022).
View Article and Find Full Text PDFWorld J Psychiatry
December 2024
Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan Province, China.
Background: Eating disorders (EDs) have increasingly become a public health problem globally, especially among children and adolescents.
Aim: To estimate the burden of EDs in children and adolescents (ages 5-19 years) at the global, regional, and national levels.
Methods: Retrieved from Global Burden of Disease Study 2019 for EDs, including anorexia nervosa and bulimia nervosa, we extracted the disability-adjusted life years (DALYs) and prevalence rates with 95% uncertainty intervals between 1990-2019.
J Clin Psychol
December 2024
Clinical and Health Psychology, Institute of Psychology and Education, Ulm University, Ulm, Germany.
J Affect Disord
December 2024
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK. Electronic address:
Background: Early diagnosis and treatment of mental illnesses is hampered by the lack of reliable markers. This study used machine learning models to uncover diagnostic and risk prediction markers for eating disorders (EDs), major depressive disorder (MDD), and alcohol use disorder (AUD).
Methods: Case-control samples (aged 18-25 years), including participants with Anorexia Nervosa (AN), Bulimia Nervosa (BN), MDD, AUD, and matched controls, were used for diagnostic classification.
J Eat Disord
December 2024
, Taranaki, New Zealand.
Background: Māori (the Indigenous people of Aotearoa New Zealand) report higher rates of eating disorders than non-Māori, but access treatment at lower rates. Diagnostic terms lacking in cultural relevance likely contribute to Māori exclusion in eating disorder spaces. Developing terms in te reo Māori (the Māori language) presents an opportunity to challenge eating disorder stereotypes and increase cultural safety in the eating disorder workforce.
View Article and Find Full Text PDFJ Eat Disord
December 2024
Division of Medicine, University College London, London, UK.
Objectives: To interview a series of individuals with bulimia nervosa of longstanding to establish their symptoms and examine the suggestion, using qualitative analysis, that the term "Severe and Enduring Bulimia Nervosa (SEED-BN)" might be appropriate and helpful.
Methods: 12 participants with Bulimia Nervosa, one male, were interviewed with the help of an interview guide. Interviews were recorded and transcribed.
Zh Nevrol Psikhiatr Im S S Korsakova
December 2024
Bekhterev National Medical Research Center of Psychiatry and Neurology of Russia, St. Petersburg, Russia.
Objective: To analyze the psychometric properties of the Eating Attitudes Test (EAT-26) in a Russian sample of patients with a depressive episode (DE) and recurrent depressive disorder (RDD).
Material And Methods: This multicenter cross-sectional study included 338 people (216, 63.9% women), aged 18-59 years, with diagnoses of DE/ RDD.
Gen Psychiatr
December 2024
Department of Nutrition, Food & Exercise, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Eur Eat Disord Rev
December 2024
Department for Medical Psychology, Psychosomatics and Psychotherapy, Medical University of Graz, Graz, Austria.
Objective: Blood-based biomarkers and neuroimaging techniques have improved our understanding of the underlying biology of eating disorders (EDs) and have increased our diagnostic portfolio.
Method: This editorial accompanies an article collection on novel biological approaches to treat EDs.
Results: The collection covers intermittent theta burst stimulation, therapeutic drug monitoring, pharmacological treatments (olanzapine, metreleptin, psychedelics, and anti-inflammatory medications), microbiome-based treatments such as pro- and prebiotics, as well as individually tailored treatment approaches for EDs.
Int J Eat Disord
December 2024
Sussex Partnership Innovation and Research in Eating Disorders (SPIRED) Clinic, Sussex Partnership Foundation Trust, Sussex, UK.
Objective: Early change in eating disorder psychopathology is the most robust predictor of treatment outcomes in eating disorders. However, little is known about what predicts early change. Using mixed-methodology, this study explored predictors of early change in the first four sessions of 10-session cognitive behavioral therapy (CBT-T) for nonunderweight eating disorders.
View Article and Find Full Text PDFActas Esp Psiquiatr
December 2024
Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, 11362 Riyadh, Saudi Arabia.
Background: Women with binge eating disorder (BED) and bulimia nervosa (BN) usually consume high-calorie meals with variable macro- and micronutrient compositions and have a disturbed perception of gastric fullness. The association of dietary intake with gastric interoception and gastric myoelectric activity (GMA) is poorly studied. This study examined the link between GMA/interoception and dietary intake in women with eating disorders (ED) compared to age/body mass index (BMI)-matched controls.
View Article and Find Full Text PDFPsychiatry Res Commun
December 2024
Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, 08854, USA.
Lisdexamfetamine (LDX) is the only medication to have gained FDA approval for the treatment of binge eating disorder (BED). LDX treatment is generally effective at reducing binge eating symptoms but is associated with several unwanted side effects. How BED patients perceive the therapeutic efficacy vs.
View Article and Find Full Text PDFMethodsX
December 2024
Psychotherapy and Psychopathology Research Lab, Psychology Research Centre (CIPsi), School of Psychology, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
The EDA-5 was translated from English to Portuguese, followed by a cross-cultural adaptation for use in Brazil and Portugal. Two independent translators worked on the Brazilian and European Portuguese versions, which were then reviewed to create a harmonized version. This version was back-translated into English and approved by the original author.
View Article and Find Full Text PDFJ Clin Psychol
December 2024
National Center for PTSD at VA Boston Healthcare System, Boston, Massachusetts, USA.
Objective: To assess, by interview, the rates of eating disorders in a nationally representative sample of recent veterans, describe their DSM-5 eating disorder diagnoses and the occurrence of comorbid psychiatric disorders. To conduct an exploratory case-control analysis of previously documented and additional specific military risk factors before eating disorder onset to inform studies of prospective risk.
Method: Using a two-stage design, probable cases and controls were identified by screening questionnaires from a sample of 1494 veterans who completed a survey study and interviewed to establish case status and confirm probable co-morbid psychiatric diagnoses.
Eur Eat Disord Rev
December 2024
Psychiatry Unit, Department of Health Sciences, University of Florence, Florence, Italy.
Objective: This study aimed to provide a BMI-adjusted meta-analytical calculation of blood leptin levels across different eating disorders (EDs) including anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), recovered EDs, and healthy controls (HCs). The goal was to understand BMI-independent leptin alterations and their potential as biomarkers.
Method: PubMed and ClinicalTrials.
J Eat Disord
December 2024
School of Journalism, Fudan University, Shanghai, China.
BMC Psychiatry
December 2024
Unit of Psychiatry and Eating Disorders, Department of Medicine (DMED), University of Udine, Udine, 33100, Italy.
Int Rev Psychiatry
November 2024
Department of Human Neurosciences, "Sapienza" University of Rome, Rome, Italy.
Health Psychol Res
October 2024
Department of Educational Sciences, Section of Psychology University of Catania.
J Esthet Restor Dent
December 2024
Department of Reconstructive Dentistry, University Center for Dental Medicine Basel UZB, University of Basel, Basel, Switzerland.
BJOG
December 2024
National Centre for Register-Based Research (NCRR), Aarhus University, Aarhus, Denmark.
Eat Behav
November 2024
OBEMET Center for Obesity and Metabolic Health, Lima, Peru; Universidad San Ignacio de Loyola, Lima, Peru; Nutrition and Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Arch Womens Ment Health
November 2024
Psychiatry Unit, Department of Health Sciences, University of Florence, Largo Brambilla 3, 50100, Florence, Italy.
Int J Eat Disord
November 2024
Eating Disorders Service, Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, UK.